Propel Bio Management LLC 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-22 2:26 pm Purchase | 2024-02-09 | 13G | Applied Therapeutics, Inc. APLT | Propel Bio Management LLC | 8,071,526 10.500% | 3,314,144 (+69.66%) | Filing |
| 2023-05-02 1:24 pm Purchase | 2023-02-28 | 13G | Applied Therapeutics, Inc. APLT | Propel Bio Management LLC | 4,757,382 9.900% | 4,757,382 (New Position) | Filing |